1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Non-Invasive Cancer Diagnostics Market, By Therapeutics
5.1 Introduction
5.2 Lung Cancer
5.3 Breast Cancer
5.4 Solid Tumors
5.5 Blood Cancer
5.6 Other Therapeutics
6 Global Non-Invasive Cancer Diagnostics Market, By Technology
6.1 Introduction
6.2 Clinical Chemistry
6.3 Spectroscopy
6.4 Immunoassay
6.5 Molecular Diagnostics
6.6 Other Technologies
7 Global Non-Invasive Cancer Diagnostics Market, End user
7.1 Introduction
7.2 Hospitals & Clinics
7.3 Ambulatory Care
7.4 Other End Users
8 Global Non-Invasive Cancer Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Gen-Probe Inc
10.2 Digene Corporation
10.3 Quest Diagnostics Inc
10.4 Genetics Inc
10.5 BIOVIEW Inc
10.6 AVIVA Biosciences Corporation
10.7 Dr Lal PathLabs Ltd.
10.8 Laboratory Corporation of America Holdings (LabCorp)
10.9 A&G Pharmaceutical
10.10 Roche Holding AG
10.11 Affymetrix Inc
10.12 Subtle Pharmaceuticals Pvt. Ltd.
10.13 Precision Therapeutics
List of Tables
Table 1 Global Non-Invasive Cancer Diagnostics Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Non-Invasive Cancer Diagnostics Market Outlook, By Therapeutics (2020-2028) ($MN)
Table 3 Global Non-Invasive Cancer Diagnostics Market Outlook, By Lung Cancer (2020-2028) ($MN)
Table 4 Global Non-Invasive Cancer Diagnostics Market Outlook, By Breast Cancer (2020-2028) ($MN)
Table 5 Global Non-Invasive Cancer Diagnostics Market Outlook, By Solid Tumors (2020-2028) ($MN)
Table 6 Global Non-Invasive Cancer Diagnostics Market Outlook, By Blood Cancer (2020-2028) ($MN)
Table 7 Global Non-Invasive Cancer Diagnostics Market Outlook, By Other Therapeutics (2020-2028) ($MN)
Table 8 Global Non-Invasive Cancer Diagnostics Market Outlook, By Technology (2020-2028) ($MN)
Table 9 Global Non-Invasive Cancer Diagnostics Market Outlook, By Clinical Chemistry (2020-2028) ($MN)
Table 10 Global Non-Invasive Cancer Diagnostics Market Outlook, By Spectroscopy (2020-2028) ($MN)
Table 11 Global Non-Invasive Cancer Diagnostics Market Outlook, By Immunoassay (2020-2028) ($MN)
Table 12 Global Non-Invasive Cancer Diagnostics Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
Table 13 Global Non-Invasive Cancer Diagnostics Market Outlook, By Other Technologies (2020-2028) ($MN)
Table 14 Global Non-Invasive Cancer Diagnostics Market Outlook, By End user (2020-2028) ($MN)
Table 15 Global Non-Invasive Cancer Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
Table 16 Global Non-Invasive Cancer Diagnostics Market Outlook, By Ambulatory Care (2020-2028) ($MN)
Table 17 Global Non-Invasive Cancer Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 18 North America Non-Invasive Cancer Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 19 North America Non-Invasive Cancer Diagnostics Market Outlook, By Therapeutics (2020-2028) ($MN)
Table 20 North America Non-Invasive Cancer Diagnostics Market Outlook, By Lung Cancer (2020-2028) ($MN)
Table 21 North America Non-Invasive Cancer Diagnostics Market Outlook, By Breast Cancer (2020-2028) ($MN)
Table 22 North America Non-Invasive Cancer Diagnostics Market Outlook, By Solid Tumors (2020-2028) ($MN)
Table 23 North America Non-Invasive Cancer Diagnostics Market Outlook, By Blood Cancer (2020-2028) ($MN)
Table 24 North America Non-Invasive Cancer Diagnostics Market Outlook, By Other Therapeutics (2020-2028) ($MN)
Table 25 North America Non-Invasive Cancer Diagnostics Market Outlook, By Technology (2020-2028) ($MN)
Table 26 North America Non-Invasive Cancer Diagnostics Market Outlook, By Clinical Chemistry (2020-2028) ($MN)
Table 27 North America Non-Invasive Cancer Diagnostics Market Outlook, By Spectroscopy (2020-2028) ($MN)
Table 28 North America Non-Invasive Cancer Diagnostics Market Outlook, By Immunoassay (2020-2028) ($MN)
Table 29 North America Non-Invasive Cancer Diagnostics Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
Table 30 North America Non-Invasive Cancer Diagnostics Market Outlook, By Other Technologies (2020-2028) ($MN)
Table 31 North America Non-Invasive Cancer Diagnostics Market Outlook, By End user (2020-2028) ($MN)
Table 32 North America Non-Invasive Cancer Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
Table 33 North America Non-Invasive Cancer Diagnostics Market Outlook, By Ambulatory Care (2020-2028) ($MN)
Table 34 North America Non-Invasive Cancer Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 35 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 36 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Therapeutics (2020-2028) ($MN)
Table 37 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Lung Cancer (2020-2028) ($MN)
Table 38 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Breast Cancer (2020-2028) ($MN)
Table 39 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Solid Tumors (2020-2028) ($MN)
Table 40 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Blood Cancer (2020-2028) ($MN)
Table 41 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Other Therapeutics (2020-2028) ($MN)
Table 42 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Technology (2020-2028) ($MN)
Table 43 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Clinical Chemistry (2020-2028) ($MN)
Table 44 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Spectroscopy (2020-2028) ($MN)
Table 45 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Immunoassay (2020-2028) ($MN)
Table 46 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
Table 47 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Other Technologies (2020-2028) ($MN)
Table 48 Europe Non-Invasive Cancer Diagnostics Market Outlook, By End user (2020-2028) ($MN)
Table 49 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
Table 50 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Ambulatory Care (2020-2028) ($MN)
Table 51 Europe Non-Invasive Cancer Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 52 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 53 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Therapeutics (2020-2028) ($MN)
Table 54 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Lung Cancer (2020-2028) ($MN)
Table 55 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Breast Cancer (2020-2028) ($MN)
Table 56 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Solid Tumors (2020-2028) ($MN)
Table 57 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Blood Cancer (2020-2028) ($MN)
Table 58 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Other Therapeutics (2020-2028) ($MN)
Table 59 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Technology (2020-2028) ($MN)
Table 60 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Clinical Chemistry (2020-2028) ($MN)
Table 61 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Spectroscopy (2020-2028) ($MN)
Table 62 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Immunoassay (2020-2028) ($MN)
Table 63 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
Table 64 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Other Technologies (2020-2028) ($MN)
Table 65 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By End user (2020-2028) ($MN)
Table 66 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
Table 67 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Ambulatory Care (2020-2028) ($MN)
Table 68 Asia Pacific Non-Invasive Cancer Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 69 South America Non-Invasive Cancer Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 70 South America Non-Invasive Cancer Diagnostics Market Outlook, By Therapeutics (2020-2028) ($MN)
Table 71 South America Non-Invasive Cancer Diagnostics Market Outlook, By Lung Cancer (2020-2028) ($MN)
Table 72 South America Non-Invasive Cancer Diagnostics Market Outlook, By Breast Cancer (2020-2028) ($MN)
Table 73 South America Non-Invasive Cancer Diagnostics Market Outlook, By Solid Tumors (2020-2028) ($MN)
Table 74 South America Non-Invasive Cancer Diagnostics Market Outlook, By Blood Cancer (2020-2028) ($MN)
Table 75 South America Non-Invasive Cancer Diagnostics Market Outlook, By Other Therapeutics (2020-2028) ($MN)
Table 76 South America Non-Invasive Cancer Diagnostics Market Outlook, By Technology (2020-2028) ($MN)
Table 77 South America Non-Invasive Cancer Diagnostics Market Outlook, By Clinical Chemistry (2020-2028) ($MN)
Table 78 South America Non-Invasive Cancer Diagnostics Market Outlook, By Spectroscopy (2020-2028) ($MN)
Table 79 South America Non-Invasive Cancer Diagnostics Market Outlook, By Immunoassay (2020-2028) ($MN)
Table 80 South America Non-Invasive Cancer Diagnostics Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
Table 81 South America Non-Invasive Cancer Diagnostics Market Outlook, By Other Technologies (2020-2028) ($MN)
Table 82 South America Non-Invasive Cancer Diagnostics Market Outlook, By End user (2020-2028) ($MN)
Table 83 South America Non-Invasive Cancer Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
Table 84 South America Non-Invasive Cancer Diagnostics Market Outlook, By Ambulatory Care (2020-2028) ($MN)
Table 85 South America Non-Invasive Cancer Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 86 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 87 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Therapeutics (2020-2028) ($MN)
Table 88 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Lung Cancer (2020-2028) ($MN)
Table 89 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Breast Cancer (2020-2028) ($MN)
Table 90 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Solid Tumors (2020-2028) ($MN)
Table 91 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Blood Cancer (2020-2028) ($MN)
Table 92 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Other Therapeutics (2020-2028) ($MN)
Table 93 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Technology (2020-2028) ($MN)
Table 94 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Clinical Chemistry (2020-2028) ($MN)
Table 95 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Spectroscopy (2020-2028) ($MN)
Table 96 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Immunoassay (2020-2028) ($MN)
Table 97 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
Table 98 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Other Technologies (2020-2028) ($MN)
Table 99 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By End user (2020-2028) ($MN)
Table 100 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
Table 101 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Ambulatory Care (2020-2028) ($MN)
Table 102 Middle East & Africa Non-Invasive Cancer Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
| ※参考情報 非侵襲的がん診断とは、身体に直接的な侵入を伴わない方法でがんを検出する技術や手法のことを指します。これにより、患者に対する身体的な負担が少なく、より迅速かつ安全に検査を行うことができます。非侵襲的なアプローチは主に血液検査や画像診断などを通じて行われ、がんの早期発見やモニタリングに大いに役立っています。 非侵襲的がん診断には、さまざまな種類があります。まず、液体生検が代表的な方法です。液体生検は血液や体液中の腫瘍DNAや循環腫瘍細胞を分析することで、がんの存在を確認します。この手法は、がんの種類やステージに関する情報を提供するだけでなく、治療の効果をモニタリングするのにも役立ちます。 次に、画像診断技術も重要な非侵襲的診断手法です。CT（コンピュータ断層撮影）、MRI（磁気共鳴画像法）、超音波検査などがあり、これらの技術は内部組織の状態を視覚化し、がん病変の有無を確認するのに用いられます。特に、CTやMRIは腫瘍の大きさや位置を把握し、他の臓器への転移の有無を調べる際に非常に有効です。 さらに、PET（陽電子放射断層撮影）も非侵襲的ながん診断法として広く用いられています。PETは、放射性同位元素を使用し、腫瘍の代謝活動を評価することでがんの存在を検出します。特に、がんがどのくらい活動的かという点を評価するために非常に精度が高いとされています。 これらの検査方法は、がんの早期発見に重要な役割を果たしています。早期にがんが発見されることで、治療の選択肢が増え、生命予後が改善する可能性があります。また、非侵襲的検査によって、患者が受ける精神的および身体的な負担が軽減されるため、検査を受けやすくなるという利点もあります。 さらに、非侵襲的がん診断技術は、研究の進展によっていまだ進化を続けています。新しいバイオマーカーの発見や、AI（人工知能）を活用した画像解析技術の向上により、がんの早期発見、診断精度の向上が期待されています。これにより、ますます多くのがん患者が早期に適切な治療を受けることができるようになるでしょう。 非侵襲的なアプローチは、今後のがん診断においてますます重要になると考えられます。がんは多様な疾患であり、一つの診断方法ではすべての症例に対応することは難しいため、複数の非侵襲的検査を組み合わせて総合的に評価することが求められています。また、新たな技術や手法の開発が進むことで、コストの低減や検査時間の短縮も期待されています。 非侵襲的がん診断は、今後のがん医療において重要な要素として位置づけられています。高齢化社会の進展に伴い、がん患者が増加する中で、これらの診断技術の普及と進化が、がんの早期発見と治療における重要なカギとなります。このように、非侵襲的がん診断は、医療の未来においてますます注目される分野となるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
-gr.jpg)
